Homology Medicines, Inc. (NASDAQ:FIXX – Get Free Report)’s share price was down 0.7% during trading on Thursday . The stock traded as low as $0.68 and last traded at $0.71. Approximately 533,822 shares changed hands during trading, an increase of 46% from the average daily volume of 364,797 shares. The stock had previously closed at […]
Homology Medicines, Inc. (NASDAQ:FIXX – Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 306,100 shares, a drop of 19.4% from the December 15th total of 380,000 shares. Based on an average daily volume of 342,200 shares, […]
Homology Medicines (NASDAQ:FIXX – Get Free Report) and GeoVax Labs (NASDAQ:GOVXW – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Earnings & Valuation This table compares Homology Medicines […]
Homology Medicines, Inc. (NASDAQ:FIXX – Get Free Report) saw a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 380,000 shares, a decline of 14.3% from the November 30th total of 443,300 shares. Based on an average daily trading volume, of 327,000 shares, the short-interest […]
Shares of Homology Medicines, Inc. (NASDAQ:FIXX – Get Free Report) fell 2.7% on Monday . The company traded as low as $1.04 and last traded at $1.08. 199,271 shares were traded during mid-day trading, a decline of 1% from the average session volume of 200,355 shares. The stock had previously closed at $1.11. Analysts Set […]